Rethinking cancer clinical trials for COVID-19 and beyond.

Gary J DohertyMehmet GoksuBruno Henrique Rala de Paula

Published in: Nature cancer (2020)

The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care.

Keyphrases

healthcare
clinical trial
papillary thyroid
squamous cell
coronavirus disease
sars cov
phase ii
palliative care
study protocol
phase iii
social support
risk assessment
chronic pain
depressive symptoms
health information
human health
loop mediated isothermal amplification